Filter News
Area of Research
- (-) Biology and Environment (16)
- (-) Isotopes (5)
- (-) National Security (2)
- Biological Systems (1)
- Clean Energy (6)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Materials (7)
- Materials for Computing (2)
- Neutron Science (11)
- Nuclear Science and Technology (2)
- Supercomputing (17)
News Topics
- (-) Biomedical (22)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (2)
- Artificial Intelligence (21)
- Big Data (15)
- Bioenergy (46)
- Biology (74)
- Biotechnology (13)
- Buildings (3)
- Chemical Sciences (12)
- Clean Water (11)
- Climate Change (43)
- Composites (5)
- Computer Science (37)
- Coronavirus (15)
- Critical Materials (1)
- Cybersecurity (19)
- Decarbonization (20)
- Energy Storage (9)
- Environment (91)
- Exascale Computing (5)
- Frontier (4)
- Fusion (2)
- Grid (9)
- High-Performance Computing (24)
- Hydropower (8)
- Irradiation (1)
- Isotopes (25)
- Machine Learning (19)
- Materials (16)
- Materials Science (11)
- Mathematics (3)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (8)
- National Security (36)
- Net Zero (2)
- Neutron Science (7)
- Nuclear Energy (9)
- Partnerships (9)
- Physics (3)
- Polymers (2)
- Quantum Science (1)
- Renewable Energy (1)
- Security (13)
- Simulation (14)
- Space Exploration (4)
- Summit (12)
- Sustainable Energy (32)
- Transformational Challenge Reactor (1)
- Transportation (5)
Media Contacts
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.